CardioKinetix Secures $50,000,000 New Round

  • Feed Type
  • Date
    12/9/2014
  • Company Name
    CardioKinetix
  • Mailing Address
    925 Hamilton Avenue Menlo Park, CA 94025 USA
  • Company Description
    CardioKinetix, Inc. is developing new technology for treating Congestive Heart Failure (CHF). This is a catheter-based intervention implanted into the heart. CHF results from damage to the heart from several causes, which affects nearly five million people in the U.S.
  • Website
    http://www.cardiokinetix.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $50,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    This financing provides the company with the capital necessary to complete the PARACHUTE IV randomized pivotal clinical trial of the Parachute Ventricular Partitioning Device for the treatment of heart failure.
  • M&A Terms
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor

Trending on Xconomy